[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100503541":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":24,"locations":29,"responsibleParty":50,"collaborators":24,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":58,"acronym":24,"eligibilityCriteria":59,"healthyVolunteers":55,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":24,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":24,"overallStatus":32,"whyStopped":24,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Mayo Clinic","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental","EXPERIMENTAL","Experimental VR",[13],"Device: Virtual reality",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham","SHAM_COMPARATOR","Sham VR",[13],[20],{"type":21,"name":22,"description":22,"armGroupLabels":23,"otherNames":24},"DEVICE","Virtual reality",[9,15],null,[26],{"name":27,"affiliation":5,"role":28},"David Cangemi","PRINCIPAL_INVESTIGATOR",[30],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Mayo Clinic in Florida","RECRUITING","Jacksonville","Florida","32224","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-81.65565,30.33218,{"lat":42,"lon":41},[45],{"name":46,"role":47,"phone":48,"phoneExt":24,"email":49},"David Cangemi, MD","CONTACT","904-953-2000","cangemi.david@mayo.edu",{"type":28,"investigatorFullName":51,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"David J. Cangemi","Principal Investigator","100503541","functional-dyspepsia-treatment-using-virtual-reality-100503541",false,"NCT05836597","Functional Dyspepsia Treatment Using Virtual Reality","Effectiveness and Safety of Virtual Reality for the Treatment of Functional Dyspepsia","Inclusion Criteria:\n\n* Symptoms of dyspepsia thought to represent functional dyspepsia, meeting Rome IV criteria\n* Had an upper endoscopy and assessment for Helicobacter pylori; if a patient is found to have H. pylori, treatment with confirmed eradication (by stool antigen test or urea breath test) will be required before the patient is eligible for study inclusion.\n* Patients will be considered for the study if they have undergone a complete history and physical examination during a previously scheduled consultation\u002Fevaluation visit with a gastroenterologist in the Mayo Clinic Florida General GI or Motility clinic.\n\nExclusion Criteria:\n\n* Symptoms are thought to represent an organic disorder (e.g., peptic ulcer disease, hepatitis, pancreatitis, inflammatory bowel disease, type I diabetes, a known malignancy, radiation-induced injury, an active infection, vasculitis, celiac disease), or patients have known uncontrolled GERD, esophagitis, eosinophilic esophagitis, or untreated H. pylori.\n* Patients with gastroparesis or cyclic vomiting syndrome.\n* Patients with prior surgery to the esophagus, stomach or duodenum.\n* Patients taking opioids.\n* Patients with motion sickness, vertigo, or a seizure disorder\n* IBS symptoms are not predominant.","ALL","18 Years","75 Years",{"count":64,"type":65},30,"ESTIMATED","INTERVENTIONAL",[68],"NA","The purpose of this study is to evaluate the effectiveness of using virtual reality to treat gastrointestinal symptoms related to functional dyspepsia.",[71],"Functional Dyspepsia","2026-01-21",{"date":74,"type":75},"2026-01-22","ACTUAL",{"date":77,"type":75},"2024-04-01",{"date":79,"type":65},"2026-12",{"name":5,"class":6},1]